Cresco Labs CRLBF
OTC CRLBF
$0.82 +0.04 (+4.94%)
At close: Aug 19, 2026 · 3:30 PM UTC

Cresco Labs (CRLBF) Non-Current Deferred Tax Liability (2019 - 2026)

Cresco Labs' (CRLBF) quarterly Non-Current Deferred Tax Liability came in at $33.8 million in Q1 2026, down 11.7% YoY from $38.3 million in Q1 2025, and up 0.54% on a QoQ basis from $33.6 million in Q4 2025.

Cresco Labs (CRLBF) Non-Current Deferred Tax Liability (2019 - 2026) Analysis & Trends

Cresco Labs (CRLBF) has 8 years of Non-Current Deferred Tax Liability data on file, last reported at $33.8 million in Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability fell 11.7% year-over-year to $33.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.8 million (down 11.7% YoY) and the FY2025 annual result came in at $33.6 million, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability grew to $33.8 million in Q1 2026, from $33.6 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $84.2 million in Q1 2022 to a low of $33.6 million in Q4 2025.
  • A 5-year average of $53.8 million and a median of $41.3 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability soared 93.39% — and 2023, when it plunged 46.16%.
  • Tracing CRLBF's Non-Current Deferred Tax Liability over 5 years: stood at $75.1 million in 2022, then sank by 46.16% to $40.5 million in 2023, then grew by 1.06% to $40.9 million in 2024, then declined by 17.78% to $33.6 million in 2025, then climbed by 0.54% to $33.8 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $33.8 million (Q1 2026), $33.6 million (Q4 2025), and $38.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn -
10 Cresco Labs 295.09 Mn 230.98 Mn 86.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 33.80 Mn
Mar 31, 2026 33.80 Mn
Dec 31, 2025 33.62 Mn
Dec 31, 2025 33.62 Mn
Sep 30, 2025 38.50 Mn
Sep 30, 2025 38.50 Mn
Jun 30, 2025 38.82 Mn
Jun 30, 2025 38.82 Mn
Mar 31, 2025 38.28 Mn
Mar 31, 2025 38.28 Mn
Sep 30, 2024 40.89 Mn
Sep 30, 2024 40.89 Mn
Jun 30, 2024 41.59 Mn
Jun 30, 2024 41.59 Mn
Mar 31, 2024 40.98 Mn
Mar 31, 2024 40.98 Mn
Dec 31, 2023 40.46 Mn
Dec 31, 2023 40.46 Mn
Sep 30, 2023 45.35 Mn
Sep 30, 2023 45.35 Mn